Literature DB >> 26064266

Expression of lncRNA-CCAT1, E-cadherin and N-cadherin in colorectal cancer and its clinical significance.

Zhenyu Ye1, Ming Zhou1, Bin Tian1, Bin Wu1, Juncheng Li1.   

Abstract

OBJECTIVE: To explore the expression and clinical significance of IncRNA-CCAT and EMT related molecule E-cadherin and N-cadherin in colorectal cancer.
METHODS: The expression of IncRNA-CCAT1, E-cadherin and N-cadherin in 37 colorectal cancer tissue and para-carcinoma tissue was detected using qRT-PCR method, and the correlation of expression level with clinical and pathological features was studied.
RESULTS: The expression of IncRNA-CCAT1 in tumor tissue was significantly higher than that in normal para-carcinoma tissue (P < 0.001), and the expression level of CCAT1was significantly correlated with local infiltration depth (P < 0.001), tumor staging (P < 0.001), vascular invasion (P < 0.001) and CA19-9 level (P < 0.001); but not related with age, gender, location of tumor, tumor differentiation level, size of primary lesion and level of CEA (P > 0.05). The expression of E-cadherin in tumor tissues was significantly lower than in normal para-carcinoma tissues (P < 0.001), and the expression of N-cadherin was significantly higher than that in normal para-carcinoma tissues. The decrease in expression of E-cadherin and increase in expression of N-cadherin were significantly correlated with local infiltration depth (P < 0.001), tumor staging (P < 0.001), vascular invasion (P < 0.001), tumor differentiation level (P < 0.001) and CA19-9 level (P < 0.001), however not related with age, gender, tumor location, size of primary lesion and CEA level (P > 0.05).
CONCLUSION: CCAT1 plays an important role in the genesis, development, invasion and metastasis; it mediates the EMT process of colorectal cancer; and it's expected to be a new marker and treatment target in colorectal diagnosis and treatment.

Entities:  

Keywords:  CCAT1; E-cadherin; EMT; N-cadherin; colorectal cancer; lncRNA

Year:  2015        PMID: 26064266      PMCID: PMC4443100     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  29 in total

Review 1.  Tumor metastasis: molecular insights and evolving paradigms.

Authors:  Scott Valastyan; Robert A Weinberg
Journal:  Cell       Date:  2011-10-14       Impact factor: 41.582

Review 2.  Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis.

Authors:  Jing Yang; Robert A Weinberg
Journal:  Dev Cell       Date:  2008-06       Impact factor: 12.270

Review 3.  Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma.

Authors:  C S Scanlon; E A Van Tubergen; R C Inglehart; N J D'Silva
Journal:  J Dent Res       Date:  2012-11-05       Impact factor: 6.116

Review 4.  Regulatory networks defining EMT during cancer initiation and progression.

Authors:  Bram De Craene; Geert Berx
Journal:  Nat Rev Cancer       Date:  2013-02       Impact factor: 60.716

5.  Mechanisms of disease: epithelial-mesenchymal transition--does cellular plasticity fuel neoplastic progression?

Authors:  Eva A Turley; Mandana Veiseh; Derek C Radisky; Mina J Bissell
Journal:  Nat Clin Pract Oncol       Date:  2008-03-18

Review 6.  Cadherins and epithelial-to-mesenchymal transition.

Authors:  Alexander Gheldof; Geert Berx
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

7.  High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer.

Authors:  Hong-Tu Zheng; De-Bing Shi; Yu-Wei Wang; Xin-Xiang Li; Ye Xu; Pratik Tripathi; Wei-Lie Gu; Guo-Xiang Cai; San-Jun Cai
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

8.  Identification of differential proteins in colorectal cancer cells treated with caffeic acid phenethyl ester.

Authors:  Yu-Jun He; Wan-Ling Li; Bao-Hua Liu; Hui Dong; Zhi-Rong Mou; Yu-Zhang Wu
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

9.  Growth arrest-specific transcript 5 associated snoRNA levels are related to p53 expression and DNA damage in colorectal cancer.

Authors:  Jonathan Krell; Adam E Frampton; Reza Mirnezami; Victoria Harding; Alex De Giorgio; Laura Roca Alonso; Patrizia Cohen; Silvia Ottaviani; Teresa Colombo; Jimmy Jacob; Loredana Pellegrino; Gordon Buchanan; Justin Stebbing; Leandro Castellano
Journal:  PLoS One       Date:  2014-06-13       Impact factor: 3.240

10.  Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer.

Authors:  László Herszényi; Fabio Farinati; Romilda Cardin; Gábor István; László D Molnár; István Hritz; Massimo De Paoli; Mario Plebani; Zsolt Tulassay
Journal:  BMC Cancer       Date:  2008-07-10       Impact factor: 4.430

View more
  43 in total

1.  Long noncoding RNA lnc-sox5 modulates CRC tumorigenesis by unbalancing tumor microenvironment.

Authors:  Kaiming Wu; Zhenxian Zhao; Kuanzhi Liu; Jian Zhang; Guanghua Li; Liang Wang
Journal:  Cell Cycle       Date:  2017-06-20       Impact factor: 4.534

Review 2.  CCAT1: an oncogenic long noncoding RNA in human cancers.

Authors:  Xiaoqiang Guo; Yuming Hua
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-16       Impact factor: 4.553

3.  Expression and clinicopathological significance of the lncRNA HOXA11-AS in colorectal cancer.

Authors:  Tong Li; Chengfei Xu; Bin Cai; Meng Zhang; Feng Gao; Jialiang Gan
Journal:  Oncol Lett       Date:  2016-09-14       Impact factor: 2.967

4.  A novel SNP in promoter region of RP11-3N2.1 is associated with reduced risk of colorectal cancer.

Authors:  Ding Ye; Yunqing Hu; Fangyuan Jing; Yingjun Li; Simeng Gu; Xiyi Jiang; Yingying Mao; Qilong Li; Mingjuan Jin; Kun Chen
Journal:  J Hum Genet       Date:  2017-10-05       Impact factor: 3.172

5.  lncRNA FAM83H-AS1 is associated with the prognosis of colorectal carcinoma and promotes cell proliferation by targeting the Notch signaling pathway.

Authors:  Song Lu; Wei Dong; Pei Zhao; Zhenjun Liu
Journal:  Oncol Lett       Date:  2017-12-05       Impact factor: 2.967

6.  LncRNA, a novel target biomolecule, is involved in the progression of colorectal cancer.

Authors:  Weihong Sun; Shaoshao Ren; Ran Li; Qingshan Zhang; Haiping Song
Journal:  Am J Cancer Res       Date:  2019-11-01       Impact factor: 6.166

7.  Down-Regulated LncRNA-HOTAIR Suppressed Colorectal Cancer Cell Proliferation, Invasion, and Migration by Mediating p21.

Authors:  Kai Lin; Hong Jiang; Ling-Ling Zhang; Yi Jiang; Yu-Xian Yang; Guo-Dong Qiu; Yu-Qi She; Jie-Ting Zheng; Chen Chen; Ling Fang; Shu-Yao Zhang
Journal:  Dig Dis Sci       Date:  2018-05-28       Impact factor: 3.199

8.  CCAT1 promotes laryngeal squamous cell carcinoma cell proliferation and invasion.

Authors:  Kun Zhuang; Qiang Wu; Senhe Jiang; Huijun Yuan; Shaomin Huang; Huijun Li
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

Review 9.  CCAT1: a pivotal oncogenic long non-coding RNA in human cancers.

Authors:  Yu Xin; Zheng Li; Jianxiong Shen; Matthew T V Chan; William Ka Kei Wu
Journal:  Cell Prolif       Date:  2016-05-01       Impact factor: 6.831

10.  Contribution of in vitro comparison of colorectal carcinoma cells from primary and metastatic lesions to elucidation of mechanisms of tumor progression and response to anticancer therapy.

Authors:  Lukáš Krbal; Veronika Hanušová; Jiří Soukup; Stanislav John; Petra Matoušková; Aleš Ryška
Journal:  Tumour Biol       Date:  2016-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.